麻疹-腮腺炎-风疹-水痘四联疫苗的研究现状  被引量:2

Research situation on measles, mumps, rubella and varicella combined vaccine

在线阅读下载全文

作  者:奚莱蕾[1] 龚杰[2] 马凌飞[2] 舒畅[2] 朱益民[1] Xi Lailei Gong Jie Ma Lingfei Shu Chang Zhu Yimin(School of Public Health,Zhejiang University School of Medicine ,Hangzhou 310031 ,China Institute of Information Science, Zhejiang Academy of Medical Sciences, Hongzhou 310013, Chin)

机构地区:[1]浙江大学医学院流行病与卫生统计学教研室,杭州310031 [2]浙江省医学科学院情报研究所,杭州310013

出  处:《国际流行病学传染病学杂志》2017年第2期135-138,共4页International Journal of Epidemiology and Infectious Disease

摘  要:麻疹-腮腺炎-风疹-水痘(MMRV)联合疫苗自21世纪初上市以来,已应用十余年,显示出良好的免疫原性,不良反应小.MMRV疫苗的引进及应用,或有助于提高接种人群的依从性,从而有效控制相关疾病的发生.本文对MMRV疫苗的现状进行综述,以期为相关机构制定免疫策略提供参考.Since early twenty-first century,combined measles,mumps,rubella and varicella (MMRV) vaccine has been used for more than 10 years,which showed good immunogenicity and little adverse reaction.Introduction and development of MMRV vaccine may help to improve the compliance of the crowd to the vaccine,so as to control the related diseases effectively.The status of MMRV vaccine is reviewed in this article to provide reference for the relevant agencies to assign immunization strategy.

关 键 词:疫苗 联合 免疫原性 安全性 

分 类 号:R186[医药卫生—流行病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象